Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 1

1(20.0%)

Phase 2

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(2)

Phase 1(1)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05384899Completed

Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol

Role: collaborator

NCT04334707Recruiting

Kidney Precision Medicine Project

Role: collaborator

NCT07246824Not ApplicableRecruiting

Expanding Access to Safe Water in Nigeria

Role: collaborator

NCT03415854Phase 2Completed

Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)

Role: collaborator

NCT03410030Phase 1Completed

Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)

Role: collaborator

NCT03128658Completed

Trauma Induced Coagulopathy and Inflammation

Role: collaborator

NCT02597556Phase 4Withdrawn

The Impact of Anthelmintic Treatment on the Incidence of Diarrheal Disease in Vietnamese School Children

Role: collaborator

NCT00700349Not ApplicableCompleted

Evaluation of Impacts of Access to Credit and Loan Size for Microcredit Clients in South Africa

Role: collaborator

All 8 trials loaded